HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?

Abstract
Primary effusion lymphoma (PEL) is a rare type of B-cell non-Hodgkin lymphoma (NHL), which predominantly occurs in HIV-infected individuals, and is pathogenetically linked with Kaposi sarcoma (KS)-associated herpes virus/human herpes virus-8 (KSHV/HHV-8) infection with or without evidence of Epstein-Barr virus (EBV) co-infection. Although uncommon, PELs have been reported in immunocompetent patients and recipients of solid organ allografts. Rare cases of KSHV(-) EBV(+) post-transplant effusion lymphomas resembling PEL have also been described, as have KSHV(-) EBV(-) effusion lymphomas, the latter including those arising in individuals with chronic liver disease. We report a unique KSHV(-) EBV(-) post-transplant effusion lymphoma associated with serum paraproteins, occurring in an HIV(-) individual, which had cytologic features and phenotype similar to PEL, and displayed a complex karyotype including isochromosome 12p and translocation t(8;22), resulting in rearrangement of c-MYC.
AuthorsJennifer S Lambe, Darryl A Oble, Subhadra V Nandula, Deborah W Sevilla, Adriana I Colovai, Mahesh Mansukhani, Ajai Chari, Vundavalli V Murty, Bachir Alobeid, Govind Bhagat
JournalHematological oncology (Hematol Oncol) Vol. 27 Issue 4 Pg. 203-10 (Dec 2009) ISSN: 1099-1069 [Electronic] England
PMID19337983 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright (c) 2009 John Wiley & Sons, Ltd.
Topics
  • Epstein-Barr Virus Infections (genetics, pathology)
  • Herpesvirus 4, Human (isolation & purification)
  • Herpesvirus 8, Human (isolation & purification)
  • Humans
  • Immunophenotyping
  • Liver Transplantation
  • Lymphoma, Primary Effusion (genetics, pathology, virology)
  • Male
  • Middle Aged
  • Plasma Cells (pathology)
  • Sarcoma, Kaposi (genetics, pathology, virology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: